Novo Biosciences based of Bar Harbor, Maine is a regenerative medicine company developing small molecule therapies that reactivate and stimulate innate healing abilities in humans and animals. (mdibl.org)
Some research efforts are closer to clinical implementation, including developing improvements in clinical management of rare diseases and trials of small molecule therapies for inherited and mosaic genetic disorders. (genome.gov)
A fruit fly model of Duchenne muscular dystrophy allowed Ruohola - Baker's lab to rapidly score small molecule therapy candidates for raising the level of sphingosine 1 - phosphate. (sciencedaily.com)